Biochemical Journal
Brief Name:
BIOCHEM J
Impact factor:
4.4 (2023)
ISSN:
0264-6021
Home Page:
Open Access:
No
Publisher:
Portland Press Ltd
Publication Frequency:
Semimonthly
Article Processing Charge:
Standard rate
£2,150/$3,500/€2,590
Discounted rate*
£1,825/$3,000/€2,200
Publication Start Year:
1906
Annual Articles:
109
Self-citation Rate:
1.6%
Chinese Academy of Sciences SCI Journal Classification:
Major category | Minor category | TOP journal | Review journal |
---|---|---|---|
Q2 BIOLOGICAL |
BIOCHEMISTRY AND MOLECULAR BIOLOGY | Yes | No |
Subject Classification:
BIOCHEMISTRY & MOLECULAR BIOLOGY
CiteScore:
CiteScore | SJR | SNIP | CiteScore ranking | ||||||
---|---|---|---|---|---|---|---|---|---|
8 | 1.612 | 0.867 |
|
H-Index:
243
SCI Index Status:
Science Citation Index Expanded
PubMed Central:
Submission Site:
Aims and Scope:
Highlighting rigorous work that explores molecular mechanisms underpinning key biological processes, the Biochemical Journal is a single-anonymous peer-reviewed leading bioscience journal publishing high-impact scientific research papers and reviews on the latest advances and mechanistic concepts in the fields of biochemistry, cellular biosciences and molecular biology.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.